by TractManager | Sep 30, 2014 | Emerging Technology Report
An intravenous agent for neoadjuvant treatment of human epidermal receptor 2 (HER2)-positive locally advanced, inflammatory, or early-stage breast cancer, in combination with trastuzumab and docetaxel. If you have a Hayes login, click here to view the full...
by TractManager | Sep 29, 2014 | Emerging Technology Report
An intravenous agent for first-line treatment of human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer in combination with trastuzumab and docetaxel.If you have a Hayes login, click here to view the full report on the Knowledge...
by TractManager | Sep 14, 2014 | Emerging Technology Report
A once-daily oral androgen receptor inhibitor for treatment of metastatic castration-resistant prostate cancer in chemotherapy-naive men.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Sep 11, 2014 | Emerging Technology Report
An oral combination drug to promote long-term weight management.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Sep 5, 2014 | Emerging Technology Report
An ex vivo lung perfusion system and proprietary perfusate for continuous normothermic perfusion of high-risk donor lungs for up to 4 hours.If you have a Hayes login, click here to view the full report on the Knowledge Center.
Recent Comments